Literature DB >> 11900289

Analysis of troponin I levels after spontaneous implantable cardioverter defibrillator shocks.

Can Hasdemir1, Nayyar Shah, Arun P Rao, Helbert Acosta, Kagari Matsudaira, Barbara R Neas, Dwight W Reynolds, Sunny Po, Ralph Lazzara, Karen J Beckman.   

Abstract

INTRODUCTION: Serum cardiac troponin I (cTnI) is a sensitive and specific marker for myocardial injury. Myocardial ischemia and/or injury can be a trigger for ventricular arrhythmias. The aim of this study was to assess the frequency and significance of elevated serum cTnI levels after spontaneous implantable cardioverter defibrillator (ICD) shocks. METHODS AND
RESULTS: Serial cTnI measurements and ECGs were performed in 35 patients with transvenous ICDs who were admitted after spontaneous ICD shocks. Elevated cTnI levels were found in 18 patients (51%). Acute coronary syndrome was diagnosed in 5 (22%) of 23 patients with known coronary artery disease. After excluding the patients with acute coronary syndrome, elevated cTnI levels were present in 13 (43%) of 30 patients: 18% of patients with < or =3 shocks and 58% of patients with >3 shocks. Patients with elevated cTnI levels received a higher number of shocks (16+/-18 vs 5+/-7; P < 0.05) and had higher total delivered energies (475+/-538 J vs 128+/-184 J; P < 0.05) compared with patients with normal cTnI. Patients with acute coronary syndrome had higher peak cTnI levels (18+/-16 ng/mL) compared with patients with elevated cTnI without acute coronary syndrome (3.8+/-4.3 ng/mL; P < 0.01).
CONCLUSION: Serum cTnI rises occur in the majority of patients after multiple (>3) spontaneous ICD discharges but are due to acute coronary syndrome only 14% of the time (22% of the time in patients with known coronary artery disease).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11900289     DOI: 10.1046/j.1540-8167.2002.00144.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  15 in total

Review 1.  Initial experience of subcutaneous implantable cardioverter defibrillators in Singapore: a case series and review of the literature.

Authors:  Tien Siang Eric Lim; Boon Yew Tan; Kah Leng Ho; Chuh Yih Paul Lim; Wee Siong Teo; Chi-Keong Ching
Journal:  Singapore Med J       Date:  2015-10       Impact factor: 1.858

2.  The subcutaneous defibrillator will replace the transvenous defibrillator.

Authors:  Ian Crozier
Journal:  J Interv Card Electrophysiol       Date:  2011-04-27       Impact factor: 1.900

3.  The Significance of Shocks in Implantable Cardioverter Defibrillator Recipients.

Authors:  Anthony Li; Amit Kaura; Nicholas Sunderland; Paramdeep S Dhillon; Paul A Scott
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-08

Review 4.  How to improve outcomes: should we put more emphasis on programming and medical care and less on patient selection?

Authors:  Laszlo Buga
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

5.  ICD shocks: not just the "straw that broke the camel's back".

Authors:  Harikrishna Tandri
Journal:  Heart Rhythm       Date:  2010-02-24       Impact factor: 6.343

Review 6.  The utility of troponin measurement to detect myocardial infarction: review of the current findings.

Authors:  Melissa A Daubert; Allen Jeremias
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

7.  Transient local injury current in right ventricular electrogram after implantable cardioverter-defibrillator shock predicts heart failure progression.

Authors:  Larisa G Tereshchenko; Mitchell N Faddis; Barry J Fetics; Karl E Zelik; Igor R Efimov; Ronald D Berger
Journal:  J Am Coll Cardiol       Date:  2009-08-25       Impact factor: 24.094

8.  Prognostic importance of defibrillator shocks in patients with heart failure.

Authors:  Jeanne E Poole; George W Johnson; Anne S Hellkamp; Jill Anderson; David J Callans; Merritt H Raitt; Ramakota K Reddy; Francis E Marchlinski; Raymond Yee; Thomas Guarnieri; Mario Talajic; David J Wilber; Daniel P Fishbein; Douglas L Packer; Daniel B Mark; Kerry L Lee; Gust H Bardy
Journal:  N Engl J Med       Date:  2008-09-04       Impact factor: 91.245

9.  Ascending-ramp biphasic waveform has a lower defibrillation threshold and releases less troponin I than a truncated exponential biphasic waveform.

Authors:  Jian Huang; Gregory P Walcott; Richard B Ruse; Scott J Bohanan; Cheryl R Killingsworth; Raymond E Ideker
Journal:  Circulation       Date:  2012-08-03       Impact factor: 29.690

10.  Troponin-I elevation in a young man with arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  William J Kostis; Ryan J Tedford; Daniel L Miller; Steven P Schulman; Gordon F Tomaselli
Journal:  J Interv Card Electrophysiol       Date:  2008-04-08       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.